» Articles » PMID: 15522238

Sphingosine-1-phosphate Lyase SPL is an Endoplasmic Reticulum-resident, Integral Membrane Protein with the Pyridoxal 5'-phosphate Binding Domain Exposed to the Cytosol

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2004 Nov 4
PMID 15522238
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Sphingosine-1-phosphate (S1P) is a sphingolipid metabolite that functions as a bioactive lipid molecule. S1P is degraded either by S1P lyase or by S1P phosphohydrolase. The gene encoding mammalian S1P lyase, SPL, has been identified. Here, we characterize the SPL protein in its expression, localization, and topology. The expression levels of the SPL protein correlated well with the dihydrosphingosine-1-phosphate (DHS1P) lyase activity in most tissues. However, liver and heart exhibited high DHS1P lyase activities compared to their SPL protein levels. The SPL mRNA expression was temporally regulated during mouse embryonal development. Immunofluorescence microscopy demonstrated that SPL is localized at the endoplasmic reticulum. Proteinase K digestion studies revealed that the large hydrophilic domain, containing the active site, faces the cytosol. This active site orientation is opposite to that of S1P phosphohydrolase, indicating that the degradation of S1P by two S1P-degrading enzymes occurs in spatially separated sides of the endoplasmic reticulum.

Citing Articles

Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?.

Foran D, Antoniades C, Akoumianakis I Nutrients. 2024; 16(19).

PMID: 39408263 PMC: 11478599. DOI: 10.3390/nu16193296.


Regulation of cellular and systemic sphingolipid homeostasis.

Kuo A, Hla T Nat Rev Mol Cell Biol. 2024; 25(10):802-821.

PMID: 38890457 DOI: 10.1038/s41580-024-00742-y.


Disorders of fatty acid homeostasis.

Vaz F, Ferdinandusse S, Salomons G, Wanders R J Inherit Metab Dis. 2024; 48(1):e12734.

PMID: 38693715 PMC: 11730842. DOI: 10.1002/jimd.12734.


Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study.

Cellini B, Pampalone G, Camaioni E, Pariano M, Catalano F, Zelante T Sci Rep. 2023; 13(1):22692.

PMID: 38123809 PMC: 10733307. DOI: 10.1038/s41598-023-50121-4.


Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?.

Martin-Hernandez D, Munoz-Lopez M, Tendilla-Beltran H, Caso J, Garcia-Bueno B, Menchen L Int J Mol Sci. 2023; 24(16).

PMID: 37628815 PMC: 10454107. DOI: 10.3390/ijms241612634.